Signal transduction by the lipopolysaccharide receptor, Toll‐like receptor‐4

Immunology - Tập 113 Số 2 - Trang 153-162 - 2004
Eva M. Pålsson‐McDermott1, Luke O'neill1
1Department of Biochemistry, Trinity College, Dublin, Ireland

Tóm tắt

SummaryAn understanding of lipopolysaccharide (LPS) signal transduction is a key goal in the effort to provide a molecular basis for the lethal effect of LPS during septic shock and point the way to novel therapies. Rapid progress in this field during the last 6 years has resulted in the discovery of not only the receptor for LPS – Toll‐like receptor 4 (TLR4) – but also in a better appreciation of the complexity of the signalling pathways activated by LPS. Soon after the discovery of TLR4, the formation of a receptor complex in response to LPS, consisting of dimerized TLR4 and MD‐2, was described. Intracellular events following the formation of this receptor complex depend on different sets of adapters. An early response, which is dependent on MyD88 and MyD88‐like adapter (Mal), leads to the activation of nuclear factor‐κB (NF‐κB). A later response to LPS makes use of TIR‐domain‐containing adapter‐inducing interferon‐β (TRIF) and TRIF‐related adapter molecule (TRAM), and leads to the late activation of NF‐κB and IRF3, and to the induction of cytokines, chemokines, and other transcription factors. As LPS signal transduction is an area of intense research and rapid progress, this review is intended to sum up our present understanding of the events following LPS binding to TLR4, and we also attempt to create a model of the signalling pathways activated by LPS.

Từ khóa


Tài liệu tham khảo

10.1126/science.2402637

10.1084/jem.179.1.269

10.1074/jbc.270.18.10482

10.1093/nar/16.9.4173

10.4049/jimmunol.141.2.547

10.1182/blood.V73.1.284.284

10.1126/science.1698311

10.1126/science.282.5396.2085

10.1074/jbc.M205966200

10.1128/iai.64.2.653-656.1996

10.1016/S1074-7613(00)80254-X

Haziot A, 1998, The induction of acute phase proteins by lipopolysaccharide uses a novel pathway that is CD14‐independent, J Immunol, 160, 2570, 10.4049/jimmunol.160.6.2570

10.1084/jem.194.1.79

10.1073/pnas.211445098

10.1074/jbc.M306802200

10.1038/ni809

10.4049/jimmunol.162.7.3749

10.1084/jem.20031076

10.1016/S1074-7613(00)80582-8

10.1074/jbc.M207873200

10.1038/41131

10.1074/jbc.M100099200

10.1038/80833

10.1074/jbc.275.4.2251

10.1038/351355b0

Dunne A, 2003, The interleukin‐1 receptor/Toll‐like receptor superfamily: signal transduction during inflammation and host defense, Sci STKE, 171

10.1128/IAI.69.3.1477-1482.2001

10.1038/86354

10.1016/S1471-4906(01)02169-X

10.1042/BJ20040172

10.1073/pnas.96.10.5645

10.1038/86342

10.1002/eji.200323381

10.1074/jbc.273.20.12203

10.1016/S1074-7613(00)80402-1

10.1074/jbc.M300562200

10.1084/jem.192.4.595

10.1016/S0960-9822(00)00700-4

10.1016/S1074-7613(00)80596-8

10.1038/35092578

10.1038/ni886

10.1038/nature01180

10.1038/ni0901-835

10.1038/nature01182

10.1038/35040600

10.1074/jbc.M301742200

10.1128/MCB.23.7.2543-2555.2003

10.1016/S0021-9258(18)45924-8

Kuno K, 1993, Structure and function of the intracellular portion of the mouse interleukin 1 receptor (type I). Determining the essential region for transducing signals to activate the interleukin 8 gene, J Biol Chem, 268, 13510, 10.1016/S0021-9258(19)38679-X

10.1126/science.271.5252.1128

10.1074/jbc.274.27.19403

10.1016/S0092-8674(02)00827-9

10.1073/pnas.082100399

10.1038/nature736

10.1074/jbc.M400785200

10.1038/383443a0

10.1038/18465

10.1074/jbc.272.13.8141

10.1126/science.270.5244.2008

10.1038/ni886

10.1126/science.1087262

10.1084/jem.20031023

10.1074/jbc.M305820200

10.1038/ni986

10.4049/jimmunol.171.8.4304

10.1038/ni921

10.1074/jbc.M308135200

10.1074/jbc.273.5.2714

10.1074/jbc.M000524200

10.1016/S1097-2765(00)80051-9

10.1006/geno.2001.6548

10.1038/35014038

10.1074/jbc.M301484200

De Weers M, 1994, B‐cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X‐linked agammaglobulinemia, J Biol Chem, 269, 23857, 10.1016/S0021-9258(19)51014-6

10.2741/A172

10.1084/jem.20021845

10.1038/ni968

10.1006/cyto.1998.0452

10.1038/ni1050

10.1074/jbc.M403068200

10.1016/S0014-5793(03)00747-6

10.1084/jem.20021790

10.1038/ni1066

Haziot A, 1995, CD14‐deficient mice are exquisitely insensitive to the effects of LPS, Prog Clin Biol Res, 392, 349

10.1084/jem.189.4.615

10.1016/S1074-7613(00)80086-2

10.4049/jimmunol.164.8.4301

10.1084/jem.194.9.1231

10.1038/ni910

10.1089/107999000312289

10.1161/01.RES.87.7.e18

10.1124/jpet.102.036640

10.1002/1521-4141(200106)31:6<1935::AID-IMMU1935>3.0.CO;2-N

10.1152/ajplung.2001.280.1.L173

10.4049/jimmunol.169.10.5874

10.1073/pnas.0308680101

10.1016/S1074-7613(02)00446-6

10.1038/35085597

Thông tin
Thông tin xuất bản

Immunology

Tập 113 Số 2

153-162

Thông tin tác giả